Combating Drug-Resistant Mutants of Anaplastic Lymphoma Kinase with Potent and Selective Type-I<sup>1/2</sup> Inhibitors by Stabilizing Unique DFG-Shifted Loop Conformation
Peichen Pan(Zhejiang University), Tingjun Hou(Pharmaceutical Biotechnology (Czechia))
Cited by 49
Related Papers
HawkDock: a web server to predict and analyze the protein–protein complex based on computational docking and MM/GBSA
|Nucleic Acids Research|2019|646
Assessing the performance of MM/PBSA and MM/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches
|Physical Chemistry Chemical Physics|2018|360
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system
|Nature Communications|2021|253
Graph Neural Networks in Modern AI-Aided Drug Discovery
|Chemical Reviews|2025|47
Targeting phosphatidylinositol 3‐kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors
|Medicinal Research Reviews|2020|43